Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 -0.004M
August 31, 2025 -0.0063M
May 31, 2025 -0.0086M
February 28, 2025 -0.0451M
November 30, 2024 0.0096M
August 31, 2024 -0.0579M
May 31, 2024 -0.0732M
February 29, 2024 -0.0009M
November 30, 2023 -0.0018M
August 31, 2023 1.136M
May 31, 2023 0.129M
February 28, 2023 0.056M
November 30, 2022 0.0066M
August 31, 2022 0.0318M
May 31, 2022 0.0353M
February 28, 2022 0.0472M
November 30, 2021 0.0363M
August 31, 2021 0.0407M
Date Value
May 31, 2021 0.00
February 28, 2021 0.414M
November 30, 2020 -0.0006M
August 31, 2020 0.0971M
May 31, 2020 0.2439M
February 29, 2020 0.00
November 30, 2019 0.00
August 31, 2019 0.00
May 31, 2019 0.00
February 28, 2019 0.00
November 30, 2018 0.0364M
August 31, 2018 0.0658M
May 31, 2018 4.133M
February 28, 2018 0.0365M
November 30, 2017 0.00
August 31, 2017 0.0196M
May 31, 2017 0.00
February 28, 2017 0.4275M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Medifast, Inc. -0.083M
Integrated BioPharma, Inc. -0.011M
BioForce Nanosciences Holdings, Inc. 0.0209M
Skinvisible, Inc. 0.00
Skinhealth Systems, Inc. -0.224M

Cash from Financing (Quarterly) Related Metrics